Skip to content

Research on Composite Inflammatory Indicators in the Diagnosis and Treatment Process of Acute Carbon Monoxide Poisoning Patients

Research on the Clinical Application of Composite Inflammatory Indicators in Patients with Acute Carbon Monoxide Poisoning

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129484
Enrollment
Unknown
Registered
2026-08-05
Start date
2026-08-10
Completion date
Unknown
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients aged 18 to 45 with acute carbon monoxide poisoning

Interventions

Mild?to?moderate carbon monoxide poisoning (COP) group & Severe poisoning group:None

Sponsors

The Second Affiliated Hospital, Guangzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1.The medical records of patients aged 18-45 who were admitted to the emergency department due to acute carbon monoxide poisoning (COP) from January 1, 2020 to December 31, 2024.

Exclusion criteria

Exclusion criteria: 1.Age 45 years; 2.Not acute carbon monoxide poisoning; 3.Has a history of carbon monoxide poisoning before, or has existing neurological cognitive disorders such as stroke, dementia or Parkinson's disease before the acute event; 4. Any serious concurrent diseases that may affect the outcome, including severe heart, liver or kidney dysfunction; 5.Has received specific supportive treatments such as therapeutic hypothermia or steroids; 6. Has not completed the follow-up neurocognitive assessment after discharge; 7. Has not obtained the available carbon monoxide hemoglobin (COHb) test value within 24 hours after arriving at the emergency department; 8.Has blood system diseases or has received cancer chemotherapy, which may affect the COHb level or the results of routine blood tests; 9. Has active infection (such as aspiration pneumonia), which has been confirmed by clinical, chest X-ray or sputum culture, and may change the COHb level or other key variables; 10. Has any other life-threatening conditions that may confuse hematological parameters.

Design outcomes

Primary

MeasureTime frame
Systemic Immune-inflammation Index (SII);

Secondary

MeasureTime frame
Pan-immune-inflammation Value (PIV);Systemic Inflammatory Response Index (SIRI);

Countries

China

Contacts

Public ContactYunyun Liang

The Second Affiliated Hospital, Guangzhou Medical University

305525147@qq.com+86 20 34152652

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 25, 2026